National Cancer Policy Forum


Type: Forum
Topics: Biomedical and Health Research, Diseases, Health Services, Coverage, and Access, Quality and Patient Safety
Board: Board on Health Care Services

The National Cancer Policy Forum serves as a trusted venue in which experts can work collaboratively to identify emerging high-priority policy issues in cancer research and care and to examine those issues through convening activities that promote discussion about opportunities for action. The forum provides a continual focus within the National Academies on cancer, addressing issues in science, clinical medicine, public health, and public policy that are relevant to the goal of reducing the cancer burden, through prevention and by improving the care and outcomes for those diagnosed with cancer. Forum activities inform stakeholders about critical policy issues through published reports and often inform consensus committee studies. The forum has members with a broad range of expertise in cancer, including patient advocates; clinicians; and basic, translational, and clinical scientists. Members represent patients, federal agencies, academia, professional organizations, nonprofits, and industry. 


View all Publications from this Activity

Upcoming Meetings

Previous Meetings

View All Previous Meetings from this Activity

Forum Members


Edward Benz, Jr., Chair

Dana-Farber Cancer Institute

Garnet Anderson 

Fred Hutchinson Cancer Research Center

Kenneth Anderson 

Dana-Farber Cancer Institute

William Bailey 

Helsinn Therapeutics (U.S.), Inc.

Karen Basen-Engquist 

The University of Texas MD Anderson Cancer Center

Chris Boshoff 

Pfizer, Inc.

Cathy Bradley 

University of Colorado Cancer Center

Otis Brawley

Johns Hopkins University

Robert Carlson 

National Comprehensive Cancer Network

Nancy Davidson

Fred Hutchinson Cancer Research Center/Seattle Cancer Alliance

George Demetri 

Dana-Farber/Harvard Cancer Center

James Doroshow 

National Cancer Institute 

Nicole Dowling 

Centers for Disease Control and Prevention

Scot Ebbinghaus 


Kojo Elenitoba-Johnson

University of Pennsylvania 

Awny Farajallah  

Bristol-Myers Squibb Company  

Stanton Gerson 

Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center

Lori Hoffman-Hogg

Department of Veterans Affairs


Linda House

Cancer Support Community 

Hedvig Hricak

Memorial Sloan Kettering Cancer Center

Roy Jensen

The University of Kansas Cancer Center

Lisa Kennedy Sheldon

Oncology Nursing Society

Samir Khleif 

Georgetown University 

Michelle Le Beau 

The University of Chicago Comprehensive Cancer Center

Mia Levy

Rush University Medical Center

J. Leonard Lichtenfeld

American Cancer Society

Neal Meropol

Flatiron Health

Martin Murphy 

CEO Roundtable on Cancer 

Randall Oyer

Lancaster General Health

Richard Pazdur

Food and Drug Administration

Richard Schilsky

American Society of Clinical Oncology

Deborah Schrag

Dana-Farber Cancer Institute

Lawrence Shulman

University of Pennsylvania Abramson Cancer Center

Dan Theodorescu

Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai

George Weiner 

University of Iowa Holden Comprehensive Cancer Center

Robert Winn

University of Illinois Cancer Center


Forum Sponsors

  • Centers for Disease Control and Prevention
  • National Institutes of Health/ National Cancer Institute
  • American Association for Cancer Research
  • American Cancer Society
  • American College of Radiology
  • American Society of Clinical Oncology
  • Association of American Cancer Institutes
  • Association of Community Cancer Centers
  • Bristol-Myers Squibb
  • Cancer Support Community
  • CEO Roundtable on Cancer
  • Flatiron Health
  • Helsinn Therapeutics (U.S.), Inc.
  • Merck
  • National Comprehensive Cancer Network
  • National Patient Advocate Foundation 
  • Novartis Oncology
  • Oncology Nursing Society
  • Pfizer Inc.
  • Society for Immunotherapy of Cancer (SITC)

Back to Top